Matthew P. Pando

Part of Merck KGaA, Serono Genetics Institute SA is a French biotechnology company specializing in synthetic DNA and genetic analysis. The company is based in Paris, France. The company was founded in 1989 by Pascal Brandys. Serono Genetics Institute was acquired by Serono SA on September 23, 2002 for $65.82 million.

ForSight VISION4, Inc. develops novel drug delivery therapies for treatment of retinal diseases. The company was founded on June 26, 009 and is headquartered in Menlo Park, CA.

ForSight VISION5, Inc. develops ocular drug delivery technologies and device solutions for ophthalmic diseases. It engages in the development of non-invasive products to replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy. Its lead product candidate is the Helios insert, a novel, non-invasive delivery system designed to allow glaucoma and ocular hypertensive patients to continually receive their medication. The company was founded by Eugene de Juan Jr., J. Andrew Corley and K. Angela Macfarlane in 2010 and is headquartered in Madison, NJ.

ForSight VISION6, Inc. provides health care services. The company is headquartered in Brisbane, CA.

Vivendi Telecom International SA provides telecommunications services. The company is headquartered in Paris, France.

Ornis SA provides outsourcing and application services to SMB. The firm offers solutions for professional IT and Internet needs like online application as a service. The firm is headquartered in Paris, France.

Normaction SA engages in providing telecommunications and computer security services to small and medium sized businesses. Its activities include telecommunication services and IT system security. The firm also offers landline telephone services like management of company subscriptions and communications, and assignment of special numbers; mobile telephone services; and, installation of PABX telephone centers. The company was founded in 1998 and is headquartered in Asnières-sur-Seine, France

Part of Debiopharm International SA, Debiovision, Inc. is a Canadian company that develops drugs and pharmaceutical products. The company is based in Montréal, Canada. Debiovision is the result of an M & A transaction between Debiopharm International SA and H3 Pharma, Inc. as of March 01, 2005.

France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin.

ForSight Labs LLC operates as an ophthalmic technology incubator. It focuses on developing and applying solutions to improve the sight, care, and quality of life of visually impaired patients. The company was founded by Eugene de Juan, Hanson S. Gifford and Henry A. Plain in 2005 and is headquartered in Menlo Park, CA.

BioQuebec is the largest biotechnology and life sciences network in Quebec, Canada. The private company is based in Bromont, Canada. BioQuebec's 130 members include companies and organizations that operate at every level of the biotechnology and life sciences innovation chain, ranging from biotechs to pharmas, contract research organizations, venture capital firms, and support organizations. The Canadian company engages in governmental representation, business development, and partnerships to support the growth of Quebec's biotechnology and life sciences industry, which creates wealth and specialized jobs, is focused on innovation and marketing, and is dedicated to improving everyone's health and quality of life. BioQuebec's actions aim to make Quebec one of the industry's most significant and valuable players on the international stage. The company was founded in 1991 by Pierre Alary, and the CEO is Mario Lebrun.

Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada.

Novartis Pharma SAS wholesales and distributes pharmaceutical products. It offers generic and branded drugs and medicines. The company is headquartered in Rueil-Malmaison, France.

Telogic A/S provides virtual mobile network services and solutions. It is a Mobile Virtual Network Operators (MVNO) that supports fixed telephony, voice over internet protocol, and broadband. The firm provides network access either as a "Full MVNO" or in service provider setup. The company was founded by Jens Fricke, Peter Daun and Per Erik Angman in 1999 and is headquartered in Birkerod, Denmark.

Sigfox SA provides Internet of Things (IoT) services. The firm offers solutions in private area network, geolocation, and connectivity. It serves the agriculture; manufacturing; supply chain and logistics; utilities and energy; retail; and insurance sectors. The company was founded by Christophe Fourtet, Thierry Bailleul, and Ludovic Le Moan in 2009 and is headquartered in Labege, France.

Fogarty Institute for Innovation is a non-profit company that believes innovation is the key to medical advancement. The company is based in Mountain View, CA. The company strives to shape the future of human health through their work. The company was founded by Thomas J. Fogarty. Andrew Cleeland has been the CEO of the company since 2017.

Springlane GmbH develops and operates an online food and kitchenware shopping portal. It provides users with a web-based platform for searching and buying cooking equipment and kitchen accessories, such as cooking pots and pans, electronic grills, rice cookers, glassware, plates and cups, utensils, and table decoration. It also offers a selection of wine and gourmet food products. The company was founded by Lars Christian Wilde, Marius Till Fritzsche, Alexander Luik, Nils Wilde, and Björn Rust in 2012 and is headquartered in Dusseldorf, Germany.

Spiral Therapeutics, Inc. manufactures pharmaceutical products. The firm also develops therapies for inner ear disorders. The company was founded by Hugo Peris, Justin S. Hanes and Eugene de Juan in 2016 and is headquartered in San Francisco, CA.

Perception Neuroscience, Inc. operates as a biopharmaceutical company, focusing on developing therapies in Neuropsychiatry. The company was founded by Jonathan Sporn and Jay Kranzler and is headquartered in New York, NY.

Orano Med SAS is a French biotechnology company that utilizes nuclear technology to develop new therapies for cancer patients with resistant forms of cancer. The company is based in Châtillon, France, and the CEO of the company is Julien Dodet. The company specializes in targeted alpha therapy treatments, which combines biological molecules to target cancer cells with the properties of lead-212 (212pb) to destroy them while limiting the impact on surrounding healthy cells. Orano Med has formed collaborations with prestigious institutions and biopharmaceutical companies to develop several treatments using 212pb combined with various targeting agents. The company has 212pb manufacturing facilities, laboratories, and R&D centers in France and the United States and is currently investing to expand its GMP-manufacturing capacities for 212pb radiolabeled pharmaceuticals. Orano Med is ultimately controlled by the Government of France.

Vensana Capital Management LLC (Vensana Capital) is a venture capital and growth equity investment firm founded in 2019 by Peter Klein Justin & Kirk G. Nielsen. The firm is headquartered in Saint Paul, Minnesota.

Gaba Therapeutics, Inc. is biotechnology company. It develops its compound GRX-917 for anxiety, depression and a broad range of neurological disorders. The company is headquartered in Newport Beach, CA.

EntheogeniX Biosciences, Inc. is a biotech company located in Wilmington, DE. EntheogeniX Biosciences is dedicated to advancing psychedelic research for the development of better medicines for mental health diseases such as depression, bipolar disorder, and schizophrenia. The joint venture company aims to innovate the mental healthcare system by harnessing the power of artificial intelligence and computational biophysics, along with a data-driven pipeline, to uncover new medicines from desired psychedelics to further help patients. EntheogeniX Biosciences is a partnership between atai life sciences and Cyclica. The company was founded by Naheed Kurji and is currently led by CEO Srinivas G. Rao since 2019.

Voyant Biotherapeutics LLC develops ocular therapeutics to solve age-related macular degeneration. The private company is based in Menlo Park, CA.

EmpathBio operates as an biotechnology company. It engages in the provision of post-traumatic stress disorder (PTSD) psychotherapy. The firm develops 3,4-Methylenedioxy-methamphetamine (MDMA)derivatives in conjunction with digital therapeutics to deliver treatments to patients. The company was founded by Florian Brand and is headquartered in New York, NY.

Perceive Biotherapeutics, Inc. is a biotech company that is focused on developing a diverse pipeline of targets and treatment modalities for various therapeutic verticals, with a particular emphasis on ophthalmology. The company is based in South San Francisco, CA. Perceive is backed by Deerfield Management and is planning to raise a series B later this year. The company was founded based on research that identified two novel protective biologies for treating retinal blindness, which were developed from collaborations in genetic science and target validation. Kristen Angela MacFarlane has been the CEO of the company since 2020.

B Cell Design SAS provides pharmaceutical services. It offers research and development services in producing antibodies. The firm serves as a platform for other diagnostic and pharmaceutical companies addressed to academic laboratories and industrial research. The company was founded in December 7, 2007 and is headquartered in Limoges, France.